Spyre Therapeutics, Inc.: Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and ...
The ONE Group Reports Preliminary Fourth Quarter and Full Year 2024 Sales Results
The ONE Group Hospitality, Inc. ("The ONE Group" or the "Company") (Nasdaq: STKS) today reported preliminary sales results for the fourth quarter and full year ended December ...
Aura Completes the Acquisition of Bluestone
ROAD TOWN, British Virgin Islands, Jan. 13, 2025 (GLOBE NEWSWIRE) -- . (TSX: ORA, B3: AURA33) (“Aura” or the “Company”), is ...
Wired9y
how-to
WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...